HAPAP is a JJPAF program designed specifically for DRG-exempt or 340B Covered Entity Hospitals including Children’s Hospital (PED), Critical Access Hospital (CAH), Disproportionate Share Hospital (DSH), Freestanding Cancer Hospital (CAN), Rural Referral Center (RRC), Sole Community Hospital (SCH) allowing them to receive free medications to give to qualified outpatients directly.
Hospitals that participate in this program are required to sign a contract and agree to on-site assessments.
The program includes these medications:
EDURANT®
(rilpivirine) Tablets
INTELENCE®
(etravirine) Tablets
INVOKAMET® †
(canagliflozin/metformin HCI) Tablets
INVOKAMET® XR†
(canagliflozin/metformin HCI) Tablets
INVOKANA®
(canagliflozin) Tablets
PREZCOBIX®
(darunavir 800mg/cobicistat 150mg) Tablets
PREZISTA®
(darunavir) Tablets
SYMTUZA® †
(darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) Tablets
XARELTO® †
(rivaroxaban) Tablets
† Please read full Prescribing Information, including Boxed Warning for: INVOKAMET®, INVOKAMET® XR, SYMTUZA®, XARELTO®
Hospitals can apply online via the HAPAP Portal.